Written by Blindness and paralysis are often the devastating consequences of little-known disease myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). An Australian research collaboration is looking to change this, making huge strides in understanding the condition which could lead to better outcomes in the future.
Medical Xpress – latest medical and health news stories